05:14 PM EDT, 05/09/2024 (MT Newswires) -- Evolent Health ( EVH ) reported Q1 adjusted income late Thursday of $0.34 per diluted share, up from 0.21 a year earlier.

Analysts polled by Capital IQ expected $0.30.

Revenue in the quarter ended March 31 rose to $639.7 million from $427.7 million a year earlier. Analysts polled by Capital IQ expected $598.9 million.

The company expects Q2 revenue of about $625 million to $645 million. Analysts in a Capital IQ poll expect $606.6 million.

Evolent now expects full-year 2024 revenue of $2.53 billion to $2.60 billion, up from its previous guidance of $2.4 billion to $2.5 billion. Analysts polled by Capital IQ expect $2.47 billion.

Evolent shares were more than 5% higher in recent after-hours activity.

Price: 28.49, Change: +1.53, Percent Change: +5.68